SE389737B - Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset - Google Patents

Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset

Info

Publication number
SE389737B
SE389737B SE7106271A SE627171A SE389737B SE 389737 B SE389737 B SE 389737B SE 7106271 A SE7106271 A SE 7106271A SE 627171 A SE627171 A SE 627171A SE 389737 B SE389737 B SE 389737B
Authority
SE
Sweden
Prior art keywords
reagents
opiumalkaloids
opiumalkaloid
preparing
determination
Prior art date
Application number
SE7106271A
Other languages
English (en)
Inventor
S Spector
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE389737B publication Critical patent/SE389737B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SE7106271A 1970-05-13 1971-05-13 Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset SE389737B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3699970A 1970-05-13 1970-05-13

Publications (1)

Publication Number Publication Date
SE389737B true SE389737B (sv) 1976-11-15

Family

ID=21891894

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7408141A SE389739B (sv) 1970-05-13 1971-05-13 Sett att pavisa opiumalkaloider
SE7106271A SE389737B (sv) 1970-05-13 1971-05-13 Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset
SE7408140A SE417970B (sv) 1970-05-13 1974-06-19 Opiumalkaloidantigen till anvendning vid framstellning av en antikropp som kan utnyttjas vid immunanalys av opiumalkaloiden i biologisk vetska
SE7408141A SE7408141L (sv) 1970-05-13 1974-06-19

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7408141A SE389739B (sv) 1970-05-13 1971-05-13 Sett att pavisa opiumalkaloider

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7408140A SE417970B (sv) 1970-05-13 1974-06-19 Opiumalkaloidantigen till anvendning vid framstellning av en antikropp som kan utnyttjas vid immunanalys av opiumalkaloiden i biologisk vetska
SE7408141A SE7408141L (sv) 1970-05-13 1974-06-19

Country Status (5)

Country Link
CA (1) CA966778A (sv)
DE (1) DE2166716C3 (sv)
DK (1) DK142145B (sv)
GB (1) GB1320056A (sv)
SE (4) SE389739B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
CN113968853B (zh) * 2020-07-22 2022-09-16 中国农业大学 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用

Also Published As

Publication number Publication date
DE2166716C3 (de) 1980-06-12
SE7408141L (sv) 1974-06-19
SE389739B (sv) 1976-11-15
SE417970B (sv) 1981-04-27
CA966778A (en) 1975-04-29
SE7408140L (sv) 1974-06-19
DK142145C (sv) 1981-02-02
DE2166716A1 (de) 1975-04-24
GB1320056A (en) 1973-06-13
DE2166716B2 (de) 1979-09-27
DE2123300B2 (de) 1976-03-04
DK142145B (da) 1980-09-08
DE2123300A1 (de) 1971-11-25

Similar Documents

Publication Publication Date Title
SE398557B (sv) Sett att medelst enzym-immunoanalys pavisa antikroppar antigener eller haptener
ES198630Y (es) Un apero de labranza.
CH547489A (de) Beschleunigungsaufnehmer.
FI51638C (sv) Reagens för bestämning av glukos
ES202406Y (es) Brida de fijacion.
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
NL176713C (nl) Fotografische kopieerinrichting.
DE2112594B2 (de) Hoehenmesser
CA935635A (en) Electrostatographic pick-off plate
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK139576B (da) Fremgangsmåde til isolering af alfa-6-desoxy-5-oxytetracyklin.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
SE382227B (sv) Forfarande for separering av amylos.
SE389737B (sv) Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
SE410768B (sv) Reagens for diagnostisering av hepatit
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
AR195956A1 (es) Procedimiento de fabricacion de un compuesto de alquenilidenohidrazinoftalazina
NL152522B (nl) Inrichting voor de vervaardiging van drijfglas.
DK124130B (da) Fremgangsmåde til fremstilling af ren hexetidin.
DK126509B (da) Fremgangsmåde til fremstilling af zearalenon.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK127001B (da) Fremgangsmåde til fremstilling af alkylsilaner.